Genpact LTD Earnings Per Share Disclosure
| Year ended December 31, | |||||||||||||||||
| 2023 | 2024 | 2025 | |||||||||||||||
| Net income | $ | 631,255 | $ | 513,670 | $ | 552,494 | |||||||||||
| Weighted average number of common shares used in computing basic earnings per common share | 182,345,548 | 178,385,972 | 173,892,795 | ||||||||||||||
| Dilutive effect of stock-based awards | 2,796,295 | 2,050,928 | 2,753,849 | ||||||||||||||
| Weighted average number of common shares used in computing dilutive earnings per common share | 185,141,843 | 180,436,900 | 176,646,644 | ||||||||||||||
| Earnings per common share | |||||||||||||||||
| Basic | $ | 3.46 | $ | 2.88 | $ | 3.18 | |||||||||||
| Diluted | $ | 3.41 | $ | 2.85 | $ | 3.13 | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 26, 2026 | Showing above |
| 2024 | Mar 3, 2025 | |
| 2023 | Feb 29, 2024 | |
| 2022 | Mar 1, 2023 | |
| 2021 | Mar 1, 2022 | |
| 2020 | Mar 1, 2021 | |
| 2019 | Mar 2, 2020 | |
| 2018 | Mar 1, 2019 | |
| 2017 | Mar 1, 2018 | |
| 2016 | Mar 1, 2017 | |
| 2015 | Feb 26, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.